Philips Respironics goes mobile with SleepMapper app and web-based solution SleepMapper helps sleep apnea patients enhance their therapy experience through personalized feedback and interactive tools
MURRYSVILLE, Pa., April 24, 2013 /PRNewswire/ -- Philips Respironics, a unit of Royal Philips Electronics (NYSE: PHG, AEX: PHIA), today announces the launch of the SleepMapper self-management system, a robust mobile and web-based solution for patients diagnosed with obstructive sleep apnea (OSA) that combines the components of feedback, education and troubleshooting. It is also the first self-management system for OSA patients that incorporates motivation enhancement therapy techniques to aid in adherence to sleep therapy. This innovative application provides sleep apnea patients with the tools they need to enhance their sleep therapy experience, demonstrating Philips' commitment to providing patient-focused solutions that help improve quality of life.
SleepMapper empowers patients who use Philips Respironics System One positive airway pressure (PAP) devices to stay involved and interested in their therapy and motivated to stay compliant. A patient can view therapy feedback, set goals and access information, resources and tutorials about sleep apnea and the Philips Respironics System One sleep therapy devices and masks.
"Having a tool like SleepMapper in the early stages of my therapy would have helped," said Sherry Johnston, sleep apnea sufferer and former contestant on NBC's 'The Biggest Loser'. "I'll now have the information I didn't have access to before. I can see results every day and the ability to set my goals is something I enjoy. SleepMapper helps me manage my sleep apnea."
OSA is characterized by a narrowing or closing of the upper airway, which causes cessation in breathing during sleep. The disorder affects approximately four percent of men and two percent of women in the United States.1 Positive airway pressure (PAP) therapy is considered the gold standard for the treatment of OSA. Unfortunately, many patients often fail to use PAP therapy. This poses a serious problem, as OSA that is left untreated or improperly managed can increase the risk of chronic conditions such as diabetes or heart disease.2,3
"Non-adherence to therapy due to poor patient education and not understanding the disease management process have been inherent obstacles to CPAP success," said Mark. S. Aloia, PhD, senior director, global clinical research at Philips Healthcare. Dr. Aloia has studied CPAP therapy for the past 15 years and believes "SleepMapper provides patients with a clear path for learning to manage treatment of their OSA. It allows patients to take ownership and develop goals to strive toward, which is important because it fosters patient engagement and instills a level of accountability."
SleepMapper has many benefits for the care provider. John Frank, senior vice president, general manager, Sleep and Respiratory Care, Philips Home Healthcare Solutions says, "There are an increasing number of business challenges for providers. Innovations such as SleepMapper can help providers continue to offer quality care while making their role more efficient. We are committed to helping clinicians and homecare providers with solutions that help their patients adhere to therapy and succeed."
SleepMapper can be downloaded to a smartphone or tablet, or accessed from a computer. It is available on Google Play, iTunes and www.sleepmapper.com. For more information about SleepMapper, the patient website is www.sleepmapper.com. The sleep professional and provider website is www.philips.us/sleepmapper.
About Royal Philips Electronics:
Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
More information on the SleepMapper
1 World Association of Sleep Medicine (2012). Sleep Apnea. Retrieved March 26, 2013, from http://www.wasmonline.org/.
2 Gottlieb, Daniel. "Epidemiology and Prevention, Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure, The Sleep Heart Health Study." Circulation. (2010): n. page. Web. 11 Jan. 2013. http://circ.ahajournals.org/content/122/4/352.short.
3 Aronsohn, Renee, Harry Whitmore, Eve Van Cauter, and Ersa Tasali. "Impact of Untreated Obstructive Sleep Apnea on Glucose Control in Type 2 Diabetes." American Journal of Respiratory and Critical Care Medicine. (2009): n. page. Web. 11 Jan. 2013. http://ajrccm.atsjournals.org/content/181/5/507.short.
SOURCE Philips Respironics